The consistent presence of PIK3CA mutations across all groups reinforces its role as a foundational driver of CRC biology, while the variable involvement of ancillary regulators such as INPP4B, TSC1, and RICTOR underscores the complexity of PI3K pathway disruption. The gene discussed is TSC1; the disease is colorectal carcinoma.